Yamazaki E, Fujimura T, Takahashi-Watanabe M, Tada S, et al. Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial. Br J Dermatol 2024 Aug 31:ljae343. doi: 10.1093.
PMID: 39215562